Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Bala P, Singh AK, Kavadipula P, Kotapalli V, et al. Oncogene 2021;40:863-874.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bala P, Singh AK, Kavadipula P, Kotapalli V, et al. Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Oncogene 2021;40:863-874.
PMID: 33262464